This Edition
ARTICLE | Clinical News
IBI-20089: Phase II start
WIR Staff
August 11, 2008 7:00 AM UTC
This quarter, Icon Bioscience will begin a sham-controlled, U.S. Phase II trial in 120 patients. ...